Blog | HemaCare

Treatment of Fibromyalgia as an Inflammatory Disease

Aug 20, 2018 10:15:00 AM / by Stacy Matthews Branch, DVM, PhD posted in cytokine release syndrome, disease state primary cells, cytokines, cytokine release


Rheumatologists are recognizing the inflammatory component of fibromyalgia and that has led to studies using disease state primary cells to determine the best treatment approaches.

Fibromyalgia is a chronic condition that is commonly considered a neurologic problem with multifocal pain as an important feature of the disease. However, rheumatologists are recognizing the inflammatory component of fibromyalgia and that pain my not be the primary feature of the condition. Other significant aspects of fibromyalgia are fatigue, sleep disorders, and cognitive impairments. Results of studies in patients with fibromyalgia suggest that excessive cytokine release may be the central cause of the development and symptomology of fibromyalgia.

Read More

CAR T Cells: Yes, Results are “Incredible” for Leukemia Clinical Trial

Feb 4, 2015 1:00:10 PM / by Daisy Goodrich posted in Cancer, CAR-T, clinical trial, cytokine release syndrome, leukemia, Basic Research, Immunotherapy (Immunology)


FDA-approved drugs for relapsed acute lymphoblastic leukemia have remission rates under 25%; experimental therapeutic CAR T cells top that at 90%.

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts